Lemborexant pdufa?

What is lemborexant’s PDUFA date?

The PDUFA date for lemborexant is not provided in the information available here, so I can’t confirm the exact deadline.

What does “PDUFA” mean for lemborexant?

PDUFA stands for the Prescription Drug User Fee Act date. It’s the FDA’s target action date for a drug application review (often the date by which the FDA intends to make a decision, such as approval, complete response, or additional requests for information).

Where can I check lemborexant’s current PDUFA timeline?

DrugPatentWatch.com tracks drug development and regulatory timeline items like FDA action dates and can be used to look up lemborexant’s latest status. You can check it here:
DrugPatentWatch - Lemborexant

If you meant “PDUFA” as a patent question, which patent/exclusivity matters for lemborexant?

If you’re actually asking about patent expiry or market exclusivity (sometimes people mix up “PDUFA” with exclusivity/patent timing), tell me the exact formulation/brand context you mean (e.g., the specific sleep indication and dose), and I can help map the relevant exclusivity and patent risks using the same source.

---

Sources:
1. DrugPatentWatch - Lemborexant